Oilin07,
The company could surprise us and start moving along quickly with RVA or.......
We could be in a repeat of Pretest with N-Assay...they were getting there and getting there....
Check out this update not too long ago on the Pretest with N-assay, it's 2021 now, will a surprise N-Assay/Pretest update coming ?....sounded like we were moving along...reading the recent RVA update..sounds like moving along too....will they get to the finish line or fizzle ?
"Dec. 16, 2019
NanoLogix Update on Phase One PreTest Development
NanoLogix is pleased to provide an update on the development of a Screening/Pretest for use in conjunction with the N-Assay Rapid Bacteria Diagnostic.
The first phase of Proof of Concept/Principle development work in the UK by a company with Global operations began on October 1st and was completed the first week of December at a cost of roughly $100,000. This phase demonstrated very positive results for Point of Care screening for one specific Candida strain and to very promising results for two bacteria that constitute the primary threats present in Urinary Tract Infections (UTI).
This was a necessary first of four phases that will carry through to patient studies in Houston planned for 2020. The next phase of development will begin in March, after the manufacture and delivery of custom antibodies for the remaining bacteria and Candida.
This schedule will lead to marketing of both the N-Assay and its associated screening pretest for UTI projected for 2021.
